Press Room 23 Nov 2023 International clinical trial finds semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity who do not have diabetes Read more → International clinical trial finds semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity who do not have diabetes
